Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Holmes

Showing results (651-660 of 671) with videos related to

Pageof 68
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2010
Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family RegistryRebecca S Holmes, Yingye Zheng, John A Baron, et al.
Journal of Medicinal Chemistry|April 12, 2017
Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute PancreatitisAnn L Walker, Nicolas Ancellin, Benjamin Beaufils, et al.
Journal of Medicinal Chemistry|March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitisPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Journal of Medicinal Chemistry|December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonistsPanayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2012
4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacyJohn Liddle, Paul Bamborough, Michael D Barker, et al.
Journal of Medicinal Chemistry|August 16, 2011
Discovery of a brain-penetrant S1P₃-sparing direct agonist of the S1P₁ and S1P₅ receptors efficacious at low oral doseEmmanuel H Demont, Sandra Arpino, Rino A Bit, et al.
Neuropsychologia|November 13, 2023
Guidelines for reporting action simulation studies (GRASS): Proposals to improve reporting of research in motor imagery and action observationMarcos Moreno-Verdú, Gautier Hamoline, Elise E Van Caenegem, et al.
Journal of Medicinal Chemistry|May 14, 2010
Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approachPanayiotis A Procopiou, Victoria J Barrett, Nicola J Bevan, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2009
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administrationMichael D Woodrow, Stuart P Ballantine, Michael D Barker, et al.
Pageof 68

Showing results (651-660 of 671) with videos related to

Sort By:
Pageof 68
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2010
Use of folic acid-containing supplements after a diagnosis of colorectal cancer in the Colon Cancer Family RegistryRebecca S Holmes, Yingye Zheng, John A Baron, et al.
Journal of Medicinal Chemistry|April 12, 2017
Development of a Series of Kynurenine 3-Monooxygenase Inhibitors Leading to a Clinical Candidate for the Treatment of Acute PancreatitisAnn L Walker, Nicolas Ancellin, Benjamin Beaufils, et al.
Journal of Medicinal Chemistry|March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitisPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2017
The discovery of potent and selective kynurenine 3-monooxygenase inhibitors for the treatment of acute pancreatitisJohn Liddle, Benjamin Beaufils, Margaret Binnie, et al.
Journal of Medicinal Chemistry|December 7, 2007
4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonistsPanayiotis A Procopiou, Rachael A Ancliff, Mark J Bamford, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2012
4-Phenyl-7-azaindoles as potent, selective and bioavailable IKK2 inhibitors demonstrating good in vivo efficacyJohn Liddle, Paul Bamborough, Michael D Barker, et al.
Journal of Medicinal Chemistry|August 16, 2011
Discovery of a brain-penetrant S1P₃-sparing direct agonist of the S1P₁ and S1P₅ receptors efficacious at low oral doseEmmanuel H Demont, Sandra Arpino, Rino A Bit, et al.
Neuropsychologia|November 13, 2023
Guidelines for reporting action simulation studies (GRASS): Proposals to improve reporting of research in motor imagery and action observationMarcos Moreno-Verdú, Gautier Hamoline, Elise E Van Caenegem, et al.
Journal of Medicinal Chemistry|May 14, 2010
Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approachPanayiotis A Procopiou, Victoria J Barrett, Nicola J Bevan, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2009
Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administrationMichael D Woodrow, Stuart P Ballantine, Michael D Barker, et al.
Pageof 68